Committees

Board committees, when used, have one essential role– to strengthen and support the work of the Board as a whole. A committee is a Board committee only if its existence and charge come from the Board, regardless of whether Board members sit on the committee.

Nominating Committee

  • Nominating Committee Details

    Products

    Product #1: Per the bylaws, preparation of a slate of up to two (2) candidates for each open Region Director position, for presentation to the membership at the House of Delegates, prior to March 1 of each year.

    Product #2: Per the bylaws, preparation of a slate of up to two (2) candidates for each open position (At-Large Director, Speaker-Elect, and President-Elect), for presentation to the membership at the House of Delegates, prior to March 1 of each year.

    Product #3: Per the bylaws, on even-years only, preparation of a slate of up to two (2) candidates for the Treasurer position, for presentation to the membership at the House of Delegates, prior to March 1 of each year.

    Product #4: Per the bylaws, preparation of a slate of candidates for each open Delegate position, for presentation to the membership at the House of Delegates, prior to March 1 of each year. The slate should include one candidate for each open position, plus at least one (1) additional candidate.

    Authority

    To incur costs not to exceed the amount approved by the board annually.

    Composition

    Chaired by the President-Elect. Also includes each Region Director (4) from the Board of Directors. Shall include additional members chosen by the Board of Directors at its August meeting (may include non-Board Members).

    Members

    Lauren Palkowski (Staff Lead), Cheryl Anderson (Chair), Deborah Bowers, Emily Russell, Erin Blackmon-Stelling, Donna Avant, Gabby Hill, Amanda Holloman, Lynn Connelly, Crystal Watts, Laceye Parker, Mary Thomas, Suha Umina, Sylvia Faulkner, Brandea Hardie, and Linda Reid

Audit Committee

  • Audit Committee Details

    Products

    Product #1: Confirmation of auditor’s independence, and recommendation to Board for engagement of auditor– by no later than June of each year.

    Product #2: Annual specification of scope of audit, prior to outside audit, consistent with Board monitoring schedule (3,4), including approval of any permitted non-audit services to be provided by the independent auditor.

    Product #3: Assurance that the auditor has unfettered access to organizational management and records.

    Product #4: Review with the independent auditor of any problems encountered performing the audit, of the audited financial statements, and of any management letter provided by the auditor.

    Product #5: “Direct Inspection” (internal audit) monitoring of compliance with the Board’s fiscal policies (Financial Condition, Asset Protection, Budget, Compensation and Benefits), as directed/scheduled by the Board per the “Monitoring CEO Performance” Policy (policy 3,4).

    Product #6: Recommendations for Board consideration regarding revisions to the Board’s fiscal policies.

    Authority

    To direct work of outside auditors, to use management time as needed for administrative support, and to incur costs not to exceed the amount approved by the Board annually.

    Composition

    Chaired by the Treasurer. Also includes the Immediate Past-President and President Elect. Only current board members may serve.

    Members

    Ron Guida (Staff Lead), William Wynn (Chair), Jennifer Baker, and Cheryl Anderson

Legislative Affairs Committee

  • Legislative Affairs Committee Details

    Product

    Product: Options and implications for Board consideration regarding legislative effects to be pursued, or decisions regarding public positions.

    Authority

    To incur costs not to exceed the amount approved by the Board annually.

    Composition

    Chaired by the Immediate Past President/Vice Chair. Also includes the President/Board Chair and President-Elect. Shall include a minimum of seven additional members, not currently serving on the Board, chosen by the Bod of Directors at its August meeting (includes non-Board Members).

    Members

    Ron Guida (Staff Lead), Jennifer Baker (Chair), Brian Clark, Cheryl Anderson, Taylor Meyers, Alyssa Norwood, William Wynn, Deborah Bowers, Lynn Connelly, Linda Reid, Sara Elizabeth Reid, Barrett Duke, L. Michelle Stokes Cakley, Jacob Jordan, Monette Sox, Patricia Fabel, David Shirley, Amber Metts, Jed Bryant, Joseph Scuro, Kayce Shealy, Ranarda Jones, Stuart Johnson, Brittany Sanders, Tremain Cooper Colin Hungerpiller, and Jim Earley

Executive Compensation Committee

  • Executive Compensation Committee Details

    Products

    Product #1: Annual CEO compensation package alternatives for Board consideration. To be presented to the Board to allow for Board decision to be made in June, to be effective October 1st.

    Product #2: Accompanying the options for Board consideration, data as to comparable compensation for similarly qualified persons in functionally comparable positions at similar organizations.

    Product #3: Contemporaneous documentation and record keeping with respect to the deliberations and decisions regarding CEO compensation.

    Authority

    To incur costs not to exceed the amount approved by the Board annually, to include compensation surveys and outside counsel to draft contract.

    Composition

    Chaired by the President/Board Chair. Also includes the Immediate Past President, President-Elect/Vice Chair, and Treasurer.

    Members

    Brian Clark (Chair), Jennifer Baker, Cheryl Anderson, and William Wynn

Constitution and Bylaws Committee

  • Constitution and Bylaws Committee Details

    Products

    Product #1: Per bylaws, upon receipt of proposal to amend bylaws submitted with signatures of 15 active members, review of such proposal with recommendations to the Board of Directors.

    Product #2: Liaison between the Board of Directors and the House of Delegates– ensuring all proposals for bylaws amendments, whether recommended by members or the Board of Directors, are shared with the House of Delegates, along with Board of Directors recommendations pertaining thereto.

    Authority

    To incur costs not to exceed the amount approved by the Board annually.

    Composition

    Chaired by the Speaker-Elect. Also includes two additional members chosen by the President/Board Chari each year at the August Board of Directors meeting (may include non-Board Members).

    Members

    Ron Guida (Staff Lead), Alyssa Norwood (Chair), Crystall Watts, Anthony DeClue, Sara Elizabeth Reid, Jacob Jordan, Thuy Kieu, Tremain Cooper, and Kuntal Patel

Awards Committee

  • Awards Committee Details

    Product

    Product: Recommendations presented for the Board’s approval each year in April, for categories and recipients of SCPhA’s annual awards.

    Authority

    To incur costs not to exceed the amount approved by the Board annually.

    Composition

    Chaired by the Immediate Past President. May include all but must include at least three (3) of the previous year’s award recipients.

    Members

    Lauren Palkowski (Staff Lead), Jennifer Baker (Chair), John Pugh, Ed Vess, Kelly Clark, Jessica Friedel, Talisha Ratliff, and Jarrod Tippins (2022 Award Recipients)

Membership Committee

  • Membership Committee Details

    Products

    Product #1: Works with SCPhA staff to increase membership and participation in SCPhA (not in Bylaws).

    Product #2: Create a membership survey to increase/maintain membership by December 2022.

    Product #3: Review results of membership survey and provide recommendations to the Board of Directors to
    increase/maintain membership by February 2023 Board Meeting.

    Product #4: Identify members to be highlighted in printed publications and social media (monthly beginning
    January 2023).

    Product #5: Evaluate membership benefits and levels for relevancy to membership; provide to the Board of
    Directors, including recommendations for change.

    Product #6: Provide a quarterly update to the Board regarding efforts for membership recruitment and contacts
    made.

    Product #7: Provide quarterly membership update/report by category to the Board (Oct, Jan, Apr, Aug
    meetings).

    Product #8: Identify at least one member in each region to serve as a point of contact for staff travel and
    recruitment (by October).

    Product #9: Recommend networking events to establish relationships.

    Authority

    To incur costs not to exceed the amount approved by the Board annually.

    Composition

    Chaired by the Director-At Large. Also includes each Region Director from the Board of Directors, chosen by the Board of Directors at its August meeting (may include non-Board Members).

    Members

    Lauren Rexford (Staff Lead), Whitney Pence (Chair), Deborah Bowers, Emily Russell, Erin Blackmon-Stelling, Donna Avant, Mary Thomas, Joanna Catravas, Linda Reid, Zoe Ayers, Whitney Gibson, Tate Cook, Talisha Ratliff, Roberta Vining, Ranarda Jones, Cicely Major, Thayra Schad, Thuy Kieu, and Erika Tillery

Education (CE) Committee

  • Education Committee Details

    Products

    Product #1: Identify potential topics and speakers/authors for SCPhA’s educational programming
    and articles in order to meet the needs of the membership.

    Product #2: Review evaluations for delivered programming; develop suggestions for future offerings.

    Product #3: Plan topic and suggest speaker(s) for Fall Pharmacy Nights by August 30.

    Product #4: Plan programming and suggest speakers for Spa Weekend by September 30.

    Product #5: Plan programming and suggest speakers for Convention and Spring Pharmacy Nights by October 30.
    a. Update BOD at October meeting

    Product #6: Oversee peer-review for journal articles and/or other CE offerings from SCPhA (per ACPE guidelines)
    and ensure approved final drafts are submitted to SCPhA staff by given deadlines.

    Product #7: Recommend topics and speakers for future CE articles in Palmetto Pharmacist.

    Product #8: Develop a standardized process for article submission and ensure articles are submitted in the
    correct format.

    Authority

    To incur costs not to exceed the amount approved by the Board annually.

    Composition

    Chaired by a member selected by the Board of Directors. Shall include a minimum of five additional members, chosen by the Board of Directors at its August meeting (may include non-Board Members).

    Members

    Lauren Palkowski (Staff Lead), Betsy Blake (Chair), Kelly Clark, Ashley Gulyas, Alyson Shirer, Kim Keeney, Alanna Scott, Reagan Barfield, Dana Lindsey, Fatima Ghzala, Tammie Robinson, Ashley Costello, Eileen Ward, and Demi Garvin

Junior Board Selection Committee

  • Junior Board Selection Committee Details

    Products

    Product #1: Review and modify JBM application as necessary.

    Product #2: Recommend changes to the application/selection process and prepare an application/selection
    process report for the December 2022 BOD meeting.

    Product #3: Evaluate current JBM program and recommend changes (due December 2022 BOD meeting).

    Product #4: Select top candidates (minimum of 6), regardless of pharmacy school affiliation, to serve as Junior
    Board Members (due April BOD meeting).

    Authority

    To incur costs not to exceed the amount approved by the Board annually.

    Composition

    Chaired by non-faculty Board of Directors

    Members

    Lauren Rexford (Staff Lead), Emily Russell (Chair), Donna Avant, Erin Blackmon-Stelling, and Whitney Pence

HOD Policy Task Force

  • HOD Policy Task Force Details

    Products

    Product #1: Work with key members of the Board of Directors and House of Delegates to put
    forward proposed policy items (not in Bylaws)

    Product #2: Evaluate and propose changes to how the House of Delegates is structured to maximize its
    effectiveness and be an engaging experience/meaningful for its delegates and guests.

    Product #3: Create a transition process for speaker-elects to take office efficiently and effectively.

    Product #4: Review and maintain policy statements to determine if current policy statements should be
    retained, updated, archived, or rescinded; submit to BOD by February 2023 meeting.

    Product #5: Solicit feedback from the House of Delegates regarding APhA policy statements at February HOD
    meeting.

    Product #6: Develop policy statements on topics referred to this committee for possible consideration by the
    Association’s House of Delegates. (to be voted on at June HOD meeting).

    Product #7: Develop policy statements on medical marijuana and pharmacist prescribed oral contraceptives.

    Product #8: Discuss policy statements submitted by members and determine if they should be moved, forwarded,
    edited, or declined.

    Product #9: Advise the Association whenever such advice is sought on policy issues related to pharmacy practice
    and management, in consultation with Professional Affairs task force.

    Product #10: Prepare a report for April BOD meeting.

    Authority

    To incur costs not to exceed the amount approved by the Board annually.

    Composition

    Chaired by Speaker; includes Speaker-elect and others selected by Speaker of the House of Delegates at the August Board of Directors meeting (may include non-Board Members).

    Members

    Lauren Rexford (Staff Lead), Taylor Meyers (Chair), Alyssa Norwood, Coriane Thomas, Kuntal Patel, CharLeigh Steverson, and Laceye Parker

Professional Affairs Task Force

  • Professional Affairs Task Force Details

    Products

    Product #1: Review all matters of inter- and intra-professional relations that will impact the professional practice of pharmacy; provide recommendations to the Board of Directors, other committees and/or task forces that may create opportunities to advance the profession of pharmacy, work with CEO on pharmacy innovations.

    Product #2: Assess results from SCPhA Workplace Conditions Survey, provide a written report of the findings along with recommendations of suggested next steps to the Board of Directors. Due by October 2022 BOD meeting unless survey gets extended then by next BOD meeting after survey ends.

    Product #3: Identify role SCPhA can have in the recently passed hormonal contraceptives bill in community based/outpatient settings (develop recommendations for resources, implementation toolkit, etc). Due by February 2023 BOD meeting (or earlier if required).

    Product #4: Reassess role SCPhA could play regarding medical marijuana and provide recommendations to the Board, due by December 2022 BOD meeting.

    Product #5: Recommend policy topics to the House of Delegates regarding above charges or other professional practice issues, due by December 2022 BOD meeting.

    Authority

    To incur costs not to exceed the amount approved by the Board annually.

    Composition

    Chaired by a member selected by the Board of Directors. Shall include a minimum of five additional members, chosen by the Board of Directors at its August meeting (may include non-Board Members).

    Members

    Ron Guida (Staff Lead), William Wynn (Chair), Deborah Bowers, Coriane Thomas, Hillari Cantrell, Ashley Gultas, Dana Lindsey, Fatima Ghzala, Shannon Faulkenberry, Ed Vess, Jordan Meyers, and Cathy Worrall